Welcome and Introduction
13:00 – 13:05
Frances Shepherd, CA
Anti-PD-1 Experience in NSCLC
13:05 – 13:20
Frances Shepherd, CA
The Value of PD-L1 Expression in NSCLC
13:20 – 13:30
Reinhard Büttner, GE
Patient Management: Example Case
13:30 – 13:45
Naiyer Rizvi, USA
NSCLC Landscape: Future Directions
13:45 – 14:00
Andrea Ardizzoni, IT
Panel Discussion
14:00 – 14:30
Reinhard Büttner, GE; Naiyer Rizvi, USA; Andrea Ardizzoni, IT
Closing Remarks
14:30
Frances Shepherd, CA
Todos os direitos reservados